Cite
HARVARD Citation
Orkin, C. et al. (2021). Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study. Lancet. 8 (11), pp. e668-e678. [Online].